0001708138-20-000116.txt : 20201211 0001708138-20-000116.hdr.sgml : 20201211 20201211160659 ACCESSION NUMBER: 0001708138-20-000116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAGELOS P ROY CENTRAL INDEX KEY: 0001013064 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201383649 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-12-09 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001013064 VAGELOS P ROY 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-12-09 4 A 0 2439 0.0 A 237088 D Common Stock 2020-10-06 5 G 0 349 0.0 D 143210 I by CLAT Common Stock 2020-11-19 5 G 0 2406 0.0 D 47786 I by Spouse as Trustee Common Stock 2020-11-19 5 G 0 2406 0.0 A 3609 I by trust for grandch Common Stock 2211 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 492.0 2020-12-09 4 A 0 27680 0.0 A 2030-12-09 Common Stock 27680 27680 D Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock. By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**P. Roy Vagelos 2020-12-10